Skip to main content

Maligne Hodentumoren: Epidemiologie und Ätiologie

  • Living reference work entry
  • First Online:
Uroonkologie

Part of the book series: Springer Reference Medizin ((SRM))

  • 180 Accesses

Zusammenfassung

Jährlich erkranken etwa 4000 Männer in Deutschland an Hodenkrebs bei ansteigender Inzidenz. Die Erkrankung ist selten bei Afrikanern und Asiaten. Der Erkrankungsgipfel liegt zwischen dem 20. und 45. Lebensjahr. 90 % aller Hodentumoren sind Keimzellneoplasien, die in fünf verschiedenen histologischen Formationen vorkommen. Klinisch unterscheidet man zwischen den reinen Seminomen, die einen Anteil von 60 % aller Keimzelltumoren haben und den Nichtseminomen, die alle übrigen histologischen Formationen umfassen. Etwa 3–5 % der Keimzelltumoren treten bilateral auf. Zur Pathogenese nimmt man an, dass vorgeburtlich in der Gonade des späteren Patienten die Vorstufe „Keimzellneoplasie in situ“ gebildet wird, aus der nach der Pubertät die adulten Keimzelltumoren hervorgehen. Die biologischen Mechanismen, die zur Entstehung der Keimzelltumoren führen, sind unbekannt, aber die folgenden klinischen Merkmale sind signifikant mit dem Auftreten des Tumors assoziiert: Maldeszensus testis, familiärer Hodenkrebs, unilaterale Hodenkrebserkrankung und schwere gonadale Dysgenesie.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Literatur

  • Andreassen KE, Grotmol T, Cvancarova MS, Johannesen TB, Fossa SD (2011) Risk of metachronous contralateral testicular germ cell tumors: a population-based study of 7102 Norwegian patients (1953–2007). Int J Cancer 129(12):2867–2874

    Article  Google Scholar 

  • Banks K, Tuazon E, Berhane K, Koh CJ, De Filippo RE, Chang A, Kim SS, Daneshmand S, Davis-Dao C, Lewinger JP, Bernstein L, Cortessis VK (2012) Cryptorchidism and testicular germ cell tumors: comprehensive meta-analysis reveals that association between these conditions diminished over time and is modified by clinical characteristics. Front Endocrinol (Lausanne) 3:182. https://doi.org/10.3389/fendo.2012.00182

    Article  Google Scholar 

  • Bertz J, Buttmann-Schweiger N, Kraywinkel K (2017) Epidemiologie bösartiger Hodentumoren in Deutschland. Onkologe 23(2):90–96

    Article  Google Scholar 

  • Busch J, Seidel C, Zengerling F (2016) Male extragonadal germ cell tumors of the adult. Oncol Res Treat 39(3):140–144

    Article  Google Scholar 

  • Dieckmann KP, Pichlmeier U (2004) Clinical epidemiology of testicular germ cell tumors. World J Urol 22:2–14

    Article  Google Scholar 

  • Dieckmann KP, Kulejewski M, Pichlmeier U, Loy V (2007) Diagnosis of contralateral Testicular Intraepithelial Neoplasia (TIN) in patients with testicular germ cell cancer: systematic two-Site biopsies are more sensitive than a single random biopsy. Eur Urol 51:175–185

    Article  Google Scholar 

  • Dieckmann KP, Hartmann JT, Classen J, Lüdde R, Diederichs M, Pichlmeier U (2008) Tallness is associated with risk of testicular cancer: evidence for the nutrition hypothesis. Br J Cancer 99:1517–1521

    Article  Google Scholar 

  • Dieckmann KP, Richter-Simonsen H, Kulejewski M, Ikogho R, Zecha H, Anheuser P, Pichlmeier U (2018) Testicular germ-cell tumours: a descriptive analysis of clinical characteristics at first presentation. Urol Int 100(4):409–419

    Article  Google Scholar 

  • Eisenberg ML, Li S, Brooks JD, Cullen MR, Baker LC (2015) Increased risk of cancer in infertile men: analysis of US claims data. J Urol 193:1596–1601

    Article  Google Scholar 

  • Frazier AL, Amatruda JF (2014) Pediatric germ cell tumors. Biology, treatment, survivorship. Springer, Berlin

    Book  Google Scholar 

  • Germa-Lluch JR, Garcia del Muro X, Maroto P, Paz-Ares L, Arranz JA, Guma J, Alba E, Sastre J, Aparicio J, Fernandez A, Barnadas A, Terrassa J, Saenz A, Almenar D, Lopez-Brea M, Climent MA, Sanchez MA, Lasso de la Vega R, Berenguer G, Perez X (2002) Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish germ-cell cancer group (GG). Eur Urol 42:553–563

    Article  Google Scholar 

  • Ghazarian AA, Trabert B, Graubard BI, Schwartz SM, Altekruse SF, McGlynn KA (2015) Incidence of testicular germ cell tumors among US men by census region. Cancer 121(23):4181–4189

    Article  Google Scholar 

  • Grasso C, Zugna D, Fiano V, Robles Rodriguez N, Maule M, Gillio-Tos A, Ciuffreda L, Lista P, Segnan N, Merletti F, Richiardi L (2016) Subfertility and risk of testicular cancer in the EPSAM case-control study. PLoS One 11(12):e0169174

    Article  Google Scholar 

  • Gurney JK, Sarfati D, Stanley J (2015) Obscure etiology, unusual disparity: the epidemiology of testicular cancer in New Zealand. Cancer Causes Control 26:561–569

    Article  Google Scholar 

  • Hanna N, Einhorn LH (2014) Testicular cancer: a reflection on 50 years of discovery. J Clin Oncol 32(28):3085–3092

    Article  Google Scholar 

  • Hemminki K, Li X (2002) Cancer risks in twins: results from the Swedish family-cancer database. Int J Cancer 99(6):873–878

    Article  Google Scholar 

  • Kharazmi E, Hemminki K, Pukkala E, Sundquist K, Tryggvadottir L, Tretli S, Olsen JH, Fallah M (2015) Cancer risk in relatives of testicular cancer patients by histology type and age at diagnosis: a joint study from five Nordic countries. Eur Urol 68(2):283–289

    Article  Google Scholar 

  • Lerro CC, McGlynn KA, Cook MB (2010) A systematic review and meta-analysis of the relationship between body size and testicular cancer. Br J Cancer 103:1467–1474

    Article  Google Scholar 

  • Litchfield K, Levy M, Orlando G, Loveday C, Law PJ, Migliorini G, Holroyd A, Broderick P, Karlsson R, Haugen TB, Kristiansen W, Nsengimana J, Fenwick K, Assiotis I, Kote-Jarai Z, Dunning AM, Muir K, Peto J, Eeles R, Easton DF, Dudakia D, Orr N, Pashayan N, Collaboration; UTC, PRACTICAL Consortium, Bishop DT, Reid A, Huddart RA, Shipley J, Grotmol T, Wiklund F, Houlston RS, Turnbull C (2017) Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor. Nat Genet 49(7):1133–1140

    Article  Google Scholar 

  • Looijenga LH, Gillis AJ, Stoop H, Biermann K, Oosterhuis JW (2011) Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance. Int J Androl 34(4 pt2):e234–e251

    Google Scholar 

  • Loveday C, Law P, Litchfield K, Levy M, Holroyd A, Broderick P, Kote-Jarai Z, Dunning AM, Muir K, Peto J, Eeles R, Easton DF, Dudakia D, Orr N, Pashayan N, UK Testicular Cancer Collaboration TPC, Reid A, Huddart RA, Houlston RS, Turnbull C (2018) Large-scale analysis demonstrates familial testicular cancer to have polygenic aetiology. Eur Urol 74(3):248–252. https://doi.org/10.1016/j.eururo.2018.05.036

  • McGlynn KA, Trabert B (2012) Adolescent and adult risk factors for testicular cancer. Nat Rev Urol 9:339–349

    Article  Google Scholar 

  • Mikuz G (2014) [Testicular cancer – a matter of geography? : epidemiology and etiopathogenesis of germ cell tumors.][Article in German]. Pathologe 35(3):211–217

    Article  Google Scholar 

  • Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM (2016) The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours. Eur Urol 70:93–105

    Article  Google Scholar 

  • Molina Saera J, Aparicio Urtasun J, Díaz Beveridge R, Palomar Abad L, Giménez Ortiz A, Ponce Lorenzo J, Montalar Salcedo J (2006) Epidemiological pattern and time trends in testicular germ-cell tumors: a single institution 20-year experience. Clin Transl Oncol 8(8):588–593

    Article  Google Scholar 

  • Nigam M, Aschebrook-Kilfoy B, Shikanov S, Eggener S (2015) Increasing incidence of testicular cancer in the United States and Europe between 1992 and 2009. World J Urol 33:623–631

    Article  Google Scholar 

  • Park SJ, Kim J, Elghiaty A, Ham WS (2018) Recent global trends in testicular cancer incidence and mortality. Medicine (Baltimore) 97(37:e12390. https://doi.org/10.1097/MD.0000000000012390

  • Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O (2007) Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med 356(18):1835–1841

    Article  Google Scholar 

  • Pleskacova J, Hersmus R, Oosterhuis JW, Setyawati BA, Faradz SM, Cools M, Wolffenbuttel KP, Lebl J, Drop SL, Looijenga LH (2010) Tumor risk in disorders of sex development. Sex Dev 4:259–269

    Article  Google Scholar 

  • Rajpert-De Meyts E, McGlynn KA, Okamoto K, Jewett MA, Bokemeyer C (2016) Testicular germ cell tumours. Lancet 387(10029):1762–1774

    Article  Google Scholar 

  • Robert Koch Institut, Gesellschaft der epidemiologischen Krebsregister Deutschland (2015) Krebs in Deutschland 2011/12. 10. Ausgabe. Robert Koch Institut, Berlin

    Google Scholar 

  • Ruf CG, Isbarn H, Wagner W, Fisch M, Matthies C, Dieckmann KP (2014) Changes in epidemiologic features of testicular germ cell cancer: age at diagnosis and relative frequency of seminoma are constantly and significantly increasing. Urol Oncol 32(1):33.e1–33.e6

    Article  Google Scholar 

  • Signal V, Huang S, Sarfati D, Stanley J, McGlynn KA, Gurney JK (2018) Dairy consumption and risk of testicular cancer: a systematic review. Nutr Cancer 70(5): 710–736

    Google Scholar 

  • Skakkebaek NE, Rajpert-De Meyts E, Buck Louis GM, Toppari J, Andersson AM, Eisenberg ML, Jensen TK, Jørgensen N, Swan SH, Sapra KJ, Ziebe S, Priskorn L, Juul A (2016) Male reproductive disorders and fertility trends: influences of environment and genetic susceptibility. Physiol Rev 96(1):55–97

    Article  Google Scholar 

  • Stang A, Bray F, Dieckmann KP, Lortet-Tieulent J, Rusner C (2015) Mortality of testicular cancer in East and West Germany 20 years after reunification: a gap not closed yet. Urol Int 95(2):160–166

    Article  Google Scholar 

  • Tandstad T, Solberg A, Håkansson U, Stahl O, Haugnes HS, Oldenburg J, Dahl O, Kjellman A, Angelsen A, Cohn-Cedermark GS (2014) Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols. Acta Oncol 54(4):493–499

    Article  Google Scholar 

  • Tsai RJ, Luckhaupt SE, Schumacher P, Cress RD, Deapen DM, Calvert GM (2015) Risk of cancer among firefighters in California, 1988–2007. Am J Ind Med 58(7):715–729

    Article  Google Scholar 

  • Woldu SL, Bagrodia A (2018) Update on epidemiologic considerations and treatment trends in testicular cancer. Curr Opin Urol 28(5):440–447

    PubMed  Google Scholar 

  • Woldu SL, Aydin AM, Rao AV, Hutchinson RC, Singla N, Clinton TN, Krabbe LM, Passoni NM, Raj GV, Miller DS, Amatruda JF, Sagalowsky AI, Lotan Y, Arriaga Y, Margulis V, Bagrodia A (2018) Differences at presentation and treatment of testicular cancer in hispanic men: institutional and national hospital-based analysis. Urology 112:103–111

    Article  Google Scholar 

  • Zeeb H, Pöttgen S, Ahrens W (2013) Epidemiologie von Hodentumoren. Onkologe 19:544–549

    Article  Google Scholar 

  • Zequi SD, da Costa WH, Santana TB, Favaretto RL, Sacomani CA, Guimaraes GC (2012) Bilateral testicular germ cell tumours: a systematic review. BJU Int 110(8):1102–1109

    Article  Google Scholar 

  • Znaor A, Lortet-Tieulent J, Jemal A, Bray F (2014) International variations and trends in testicular cancer incidence and mortality. Eur Urol 65:1095–1106

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Klaus-Peter Dieckmann .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Dieckmann, KP., Heidenreich, A. (2019). Maligne Hodentumoren: Epidemiologie und Ätiologie. In: Rübben, H., Hakenberg, O., Grimm, MO., Burger, M. (eds) Uroonkologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54652-9_61-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-54652-9_61-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-54652-9

  • Online ISBN: 978-3-662-54652-9

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics